All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
IBB real return snapshot: after CPI-U inflation, IBB returned +33.08% over the past year and +23.75% YTD, with dividends reinvested. Since Feb. 9, 2001, IBB is up +250.14% in real purchasing-power return, or +4.99%/yr, and is currently −0.85% below its real total-return high on Feb. 8, 2021.
Data ending Fri Oct. 30, 2026
| Fri 2001-02-09💬 to Fri 2026-10-30 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| IBB × |
+250.14%
+4.99%/yr |
+7.99%/yr
R2=0.803 |
||||
| iShares Biotechnology ETF NASDAQ Exchange-Traded Fund | ||||||
| Fri 2001-02-09💬 to Fri 2026-10-30 |
Start
Value |
End
Value |
|---|---|---|
| IBB × |
$10,000.00
2001-02-09 |
$35,013.52
2026-10-30 |
| YTD | YoY | |
|---|---|---|
| IBB × | +23.75% | +33.08% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| IBB × |
−0.85%
on 2026-10-30 from 2021-02-08 peak |
−63.31%
on 2002-07-10 from 2001-06-05 peak |
| Period ending Fri 2026-10-30 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| IBB × | +33.08% |
+43.29% +19.70%/yr |
+76.54% +20.86%/yr |
+12.95% +2.46%/yr |
+83.87% +6.28%/yr |
| Year | IBB |
|---|---|
| 2026 (YTD) | +23.75% |
| 2025 | +24.65% |
| 2024 | −5.14% |
| 2023 | +0.40% |
| 2022 | −18.93% |
| 2021 | −5.69% |
| 2020 | +24.32% |
| 2019 | +22.62% |
| 2018 | −11.22% |
| 2017 | +18.57% |
| 2016 | −23.01% |
| 2015 | +10.75% |
| 2014 | +32.83% |
| 2013 | +63.09% |
| 2012 | +29.88% |
| 2011 | +8.49% |
| 2010 | +13.15% |
| 2009 | +12.12% |
| 2008 | −12.36% |
| 2007 | +0.41% |
| 2006 | −1.80% |
| 2005 | −0.95% |
| 2004 | +1.49% |
| 2003 | +43.11% |
| 2002 | −47.06% |
| 2001 | −10.60% |
